Economic analysis alongside clinical trials: Bias in the assessment of economic outcomes

International Journal of Technology Assessment in Health Care

Volumn 12, Issue 4, 1996, Pages 691-697

  Ellwein, Leon B ^a   Drummond, Michael F ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; HEALTH SERVICE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SELECTION; REVIEW; RISK ASSESSMENT; SOCIOECONOMICS;

EID: 0030454469     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300010977     Document Type: Review

References (9)

1. Adams, M. E., McCall, N. T., Gray, D. T., et al. Economic analysis in randomized control trials. Medical Care, 1992, 30, 231-43.
2. Briggs, A., Sculpher, M., & Buxton, M. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Economics, 1994, 3, 95-104.
3. Cooper, R., & Kaplan, R. S. Measure costs right: Make the right decisions. Harvard Business Review, 1988, 66, 96-103.
4. Drummond, M. F., & Davies, L. Economic analysis alongside clinical trials: Revisiting the methodological issues. International Journal of Technological Assessment of Health Care, 1991, 7, 561-73.
5. Drummond, M. F., & Stoddart, G. L. Economic analysis and clinical trials. Controlled Clinical Trials, 1984, 5, 115-28.
6. Freund, D. A., Evans, D., Henry, D., et al. Implications of the Australian guidelines for the United States. Health Affairs, 1992, 11, 202-06.
7. Friedman, L. M., Furberg, C. D., & DeMets, D. L. Fundamentals of clinical trials, 2nd ed. Littleton, MA: PSG Publishing Company, Inc., 1985.
8. Kaplan, R. S. Management accounting for advanced technological environments. Science, 1989, 245, 819-23.
9. Pare, T. P. A new tool for managing costs. Fortune, June 14, 1993, 124-29.